|
BBOT BridgeBio Oncology Therapeutics Inc 1869105 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-42,106,000.00 |
| Balance Sheet |
|
Current Assets
|
$266,502,000.00 |
|
Assets
|
$417,646,000.00 |
|
Current Liabilities
|
$43,260,000.00 |
|
Liabilities
|
$45,366,000.00 |
|
Equity
|
$372,280,000.00 |
|
Shares Out
|
80088931.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-35,917,000.00 |
|
Investing Cash Flow
|
$-285,407,000.00 |
| Market Analysis |
Market Cap
|
$680,755,913.50 |
|
Price
|
$8.14 |
|
BVPS
|
4.65 |
|
PB
|
1.83 |
|
EPS
|
-526.11 |
|
FCF
|
$-35,941,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:24 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.49 |
|
|
2026-05-12 |
-526.11 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BBOT documents filed with the SEC.
BBOT Filings
Clear
